Literature DB >> 7576869

The ultrastructure, kinetics and intralobular distribution of apoptotic hepatocytes after portal branch ligation with special reference to their relationship to necrotic hepatocytes.

K Ikeda1, H Kinoshita, K Hirohashi, S Kubo, K Kaneda.   

Abstract

Apoptosis was originally defined as shrinkage necrosis, as a distinct mode of cellular death from coagulative necrosis in the rat liver lobes after portal branch ligation. To reveal the functional role of the apoptosis of hepatocytes in the volume reduction and recovery of normal hepatic architecture in portal-deprived liver lobes, we ligated the portal vein branch supplying the left and median liver lobes in Wistar rats. The liver lobes were perfusion-fixed with glutaraldehyde solution via the proximal site of the ligated portion of the portal vein on Days 1, 2, 4, 7 and 14 after operation and examined light and electron microscopically. On Day 2 after ligation, massive necrosis of hepatocytes occurred in the central to intermediate zones of the liver lobule, and apoptotic hepatocytes were observed in the boundary region between necrotic and normal areas. Such necrotic area-associated apoptosis of hepatocytes was most frequent on Day 2, declining thereafter. The sequential changes of the cell organelles in apoptotic hepatocytes were distinct from those in necrotic hepatocytes. On Day 7, when necrotic areas had almost disappeared the apoptosis of hepatocytes occurred mostly between intact hepatocytes in the "combined hepatic cell cords" which included no obvious sinusoidal lumen between hepatic cell cords. Such necrotic area-nonassociated apoptosis began to increase in frequency on Day 4, reached a peak on Day 7 and was gone by Day 14, when normal hepatic architecture was recovered. The present study suggests that both necrotic area-associated and non-associated apoptosis of hepatocytes may be induced by mild ischemia and contribute in part to the volume reduction of ligated liver lobes. It further reveals that the necrotic area-non-associated apoptosis of hepatocytes plays a role in reconstructing the architecture of hepatic cell cords after necrotic hepatocytes have undergone dissolution in the liver lobule.

Entities:  

Mesh:

Year:  1995        PMID: 7576869     DOI: 10.1679/aohc.58.171

Source DB:  PubMed          Journal:  Arch Histol Cytol        ISSN: 0914-9465


  6 in total

1.  Portal vein embolization: rationale, technique, and current application.

Authors:  Benjamin J May; David C Madoff
Journal:  Semin Intervent Radiol       Date:  2012-06       Impact factor: 1.513

2.  Spontaneous regression of diffuse intrahepatic recurrence with portal vein tumor thrombus after resection of hepatocellular carcinoma.

Authors:  Akihiro Okano; Hiroshi Takakuwa; Takefumi Nakamura
Journal:  Clin J Gastroenterol       Date:  2010-12-14

Review 3.  Liver Trauma: Until When We Have to Delay Surgery? A Review.

Authors:  Inés Cañas García; Julio Santoyo Villalba; Domenico Iovino; Caterina Franchi; Valentina Iori; Giuseppe Pettinato; Davide Inversini; Francesco Amico; Giuseppe Ietto
Journal:  Life (Basel)       Date:  2022-05-06

4.  [Right portal vein ligation prior to extended right hemihepatectomy for synchronous colorectal liver metastases].

Authors:  A H Hölscher; K Schleimer; K T E Beckurts; H G Brochhagen; D L Stippel
Journal:  Chirurg       Date:  2003-09       Impact factor: 0.955

5.  Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant.

Authors:  Dieter C Broering; Christian Hillert; Gerrit Krupski; Lutz Fischer; Lars Mueller; Eike G Achilles; Jan Schulte am Esch; Xavier Rogiers
Journal:  J Gastrointest Surg       Date:  2002 Nov-Dec       Impact factor: 3.267

6.  Demonstration of metabolic and cellular effects of portal vein ligation using multi-modal PET/MRI measurements in healthy rat liver.

Authors:  András Fülöp; Attila Szijártó; László Harsányi; András Budai; Damján Pekli; Diána Korsós; Ildikó Horváth; Noémi Kovács; Kinga Karlinger; Domokos Máthé; Krisztián Szigeti
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.